Company profile
PROCYON CORP CIK 812306
Industry
Pharmaceutical Preparations
Headquarters
Clearwater, FL 33756
Fiscal year end
2024 (FY)
Key Financials
Revenue
$4.98M
Net income
-$341.1K
Total assets
$3.20M
Total liabilities
$917.1K
Stockholders' equity
$2.29M
Cash & equivalents
—
Operating income
-$231.7K
Operating cash flow
-$61.3K
Capital expenditures
$63.9K
Fiscal year 2024, via 10-K filed 2024-10-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-4.6%
Net margin
-6.8%
Free cash flow
-$125.2K
Free cash flow margin
-2.5%
Liabilities / assets
28.6%
Equity / assets
71.4%
CapEx / revenue
1.3%
Operating cash flow / net income
0.18×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
$4.98M
-$341.1K
$3.20M
$917.1K
$2.29M
2023
$4.69M
-$50.2K
$3.56M
$946.0K
$2.62M
2022
$4.84M
-$209.8K
$3.80M
$1.13M
$2.67M
2021
$4.72M
$694.3K
$4.27M
$1.39M
$2.88M
2020
$4.33M
$111.7K
$2.82M
$657.9K
$2.16M
Company Details
SIC code
2834
State of incorporation
CO
Active filer
Yes
Most recent SEC filing
Form 15-12G
2024-11-08
Financials filed via
Form 10-K
filed 2024-10-25
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Clearwater, FL 33756
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:24 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.